赫赛丁的心脏毒性—培训课件.pptVIP

Cardiac Safety Analysis of Doxorubicin and Cyclophosphamide Followed by Paclitaxel With or Without Trastuzumab in the North Central Cancer Treatment Group N9831 Adjuvant Breast Cance Trial J Clin Oncol 26:1231-1238. ? 2008 by American Society of Clinical Oncology 苏贺 背景 大约20%的初发的侵袭的乳腺癌患者,存在着HER-2过表达。HER-2阳性的乳腺癌患者,疾病进展更快,也更容易复发。CA方案是早期乳腺癌患者辅助化疗的一线方案。它能够显著的提高患者的无